Zentalis Pharmaceuticals (ZNTL) Capital Expenditures (2019 - 2026)
Zentalis Pharmaceuticals' quarterly Capital Expenditures came in at $34000.0 in Q1 2026, down 81.22% quarter-over-quarter from $181000.0 in Q2 2024.
Zentalis Pharmaceuticals has reported Capital Expenditures for 7 years, with the latest figure at $34000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures changed N/A year-over-year to $34000.0; the trailing twelve-month figure through Mar 2026 stood at $34000.0 (down 81.22% YoY), and the FY2024 full-year result was $221000.0, down 62.09% from the prior year.
- Capital Expenditures for Q1 2026 stood at $34000.0, down from $181000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $2.3 million in Q3 2022, with the low at -$135000.0 in Q2 2022.
- Average Capital Expenditures over 4 years is $338600.0, with a median of $166500.0 recorded in 2022.
- Year-over-year, Capital Expenditures tumbled 101.49% in 2022 and surged 336.3% in 2023.
- Tracing ZNTL's Capital Expenditures over 4 years: stood at $160000.0 in 2022, then gained by 8.12% to $173000.0 in 2023, then grew by 4.62% to $181000.0 in 2024, then slumped by 81.22% to $34000.0 in 2026.
- The last three Capital Expenditures figures came in at $34000.0 (Q1 2026), $181000.0 (Q2 2024), and $40000.0 (Q1 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 133.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 230.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 21.83 Mn |
| 10 | Zentalis Pharmaceuticals | 280.35 Mn | 280.35 Mn | - | 34,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34,000.00 |
| Mar 31, 2026 | 34,000.00 |
| Jun 30, 2024 | 181,000.00 |
| Jun 30, 2024 | 181,000.00 |
| Mar 31, 2024 | 40,000.00 |
| Mar 31, 2024 | 40,000.00 |
| Dec 31, 2023 | 173,000.00 |
| Dec 31, 2023 | 173,000.00 |
| Sep 30, 2023 | 91,000.00 |
| Sep 30, 2023 | 91,000.00 |
| Jun 30, 2023 | 319,000.00 |
| Jun 30, 2023 | 319,000.00 |
| Dec 31, 2022 | 160,000.00 |
| Dec 31, 2022 | 160,000.00 |
| Sep 30, 2022 | 2.30 Mn |
| Sep 30, 2022 | 2.30 Mn |
| Jun 30, 2022 | -135,000.00 |
| Jun 30, 2022 | -135,000.00 |
| Mar 31, 2022 | 226,000.00 |
| Mar 31, 2022 | 226,000.00 |
| Dec 31, 2021 | 2.19 Mn |
| Dec 31, 2021 | 2.19 Mn |
| Sep 30, 2021 | 3.92 Mn |
| Sep 30, 2021 | 3.92 Mn |
| Jun 30, 2021 | -67,000.00 |
| Jun 30, 2021 | -67,000.00 |
| Mar 31, 2021 | 67,000.00 |
| Mar 31, 2021 | 67,000.00 |
| Dec 31, 2020 | 661,000.00 |
| Dec 31, 2020 | 661,000.00 |
| Sep 30, 2020 | 41,000.00 |
| Sep 30, 2020 | 41,000.00 |
| Jun 30, 2020 | 25,000.00 |
| Jun 30, 2020 | 25,000.00 |
| Mar 31, 2020 | 31,000.00 |
| Mar 31, 2020 | 31,000.00 |
| Dec 31, 2019 | -316,000.00 |
| Dec 31, 2019 | -316,000.00 |
| Sep 30, 2019 | 107,000.00 |
| Sep 30, 2019 | 107,000.00 |
| Jun 30, 2019 | 202,000.00 |
| Jun 30, 2019 | 202,000.00 |
| Mar 31, 2019 | 7,000.00 |
| Mar 31, 2019 | 7,000.00 |